Study to Evaluate the Safety and Efficacy of Two Fixed Dose Combinations of Irbesartan / Amlodipine and Monotherapy After Eight Weeks of Treatment in Subjects With Uncomplicated Mild to Moderate Essential Hypertension.

Trial Profile

Study to Evaluate the Safety and Efficacy of Two Fixed Dose Combinations of Irbesartan / Amlodipine and Monotherapy After Eight Weeks of Treatment in Subjects With Uncomplicated Mild to Moderate Essential Hypertension.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Amlodipine; Amlodipine/irbesartan; Irbesartan
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms I-COMBO
  • Most Recent Events

    • 12 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
    • 12 Feb 2010 Actual patient number (284) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top